References
- Bailey CS, Moldenhauer HJ, Park SM, et al. KCNMA1-linked channelopathy. J Gen Physiol. 2019;151(10):1173–1189.
- Dworetzky SI, Trojnacki JT, Gribkoff VK. Cloning and expression of a human large-conductance calcium-activated potassium channel. Brain Res Mol Brain Res. 1994;27(1):189–193.
- Gonzalez-Perez V, Lingle CJ. Regulation of BK channels by beta and gamma subunits. Annu Rev Physiol. 2019;81:113–137.
- Yang H, Zhang G, Cui J. BK channels: multiple sensors, one activation gate. Front Physiol. 2015;6:29.
- Moldenhauer HJ, Matychak KK, Meredith AL. Comparative gain-of-function effects of the KCNMA1-N999S mutation on human BK channel properties. J Neurophysiol. 2020;123(2):560–570.
- Li X, Poschmann S, Chen Q, et al. De novo BK channel variant causes epilepsy by affecting voltage gating but not Ca2+ sensitivity. Eur J Hum Genet. 2018;26(2):220–229.
- Wang B, Rothberg BS, Brenner R. Mechanism of increased BK channel activation from a channel mutation that causes epilepsy. J Gen Physiol. 2009;133(3):283–294.
- Junqiu Yang GK, Saxena A, Zhang G, et al. An epilepsy/dyskinesia-associated mutation enhances BK channel activation by potentiating Ca2+ sensing. Neuron. 2010;66:871–883.
- Du W, Bautista JF, Yang H, et al. Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder. Nat Genet. 2005;37(7):733–738.
- Diez-Sampedro A, Silverman WR, Bautista JF, et al. Mechanism of increased open probability by a mutation of the BK channel. J Neurophysiol. 2006;96(3):1507–1516.
- Zhang G, Gibson RA, McDonald M, et al. A gain-of-function mutation in KCNMA1 causes dystonia spells controlled with stimulant therapy. Mov Disord. 2020;35(10):1868–1873.
- Liang L, Li X, Moutton S, et al. De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes. Hum Mol Genet. 2019;28(17): 2937–295.
- Moldenhauer H, Park SM, Meredith AL. Characterization of new human KCNMA1 loss-of-function mutations. Biophys J. 2020;118(3):114a.
- Buckley C, Williams J, Munteanu T, et al. Status dystonicus, oculogyric crisis and paroxysmal dyskinesia in a 25 year-old woman with a novel KCNMA1 variant, K457E. Tremor Other Hyperkinet Mov. 2020;10:49.
- Du X, Carvalho-de-Souza JL, Wei C, et al. Loss-of-function BK channel mutation causes impaired mitochondria and progressive cerebellar ataxia. Proc Natl Acad Sci. 2020;117(11):6023–6034.
- Tang QY, Zhang Z, Meng XY, et al. Structural determinants of phosphatidylinositol 4,5-bisphosphate (PIP2) regulation of BK channel activity through the RCK1 Ca2+ coordination site. J Biol Chem. 2014;289(27):18860–18872.
- Liu HW, Hou PP, Guo XY, et al. Structural basis for calcium and magnesium regulation of a large conductance calcium-activated potassium channel with beta1 subunits. J Biol Chem. 2014;289(24):16914–16923.
- Hou P, Zeng W, Gan G, et al. Inter-alpha/beta subunits coupling mediating pre-inactivation and augmented activation of BKCa beta2. Sci Rep. 2013;3:1666.
- Schreiber M, Salkoff L. A novel calcium-sensing domain in the BK channel. Biophys J. 1997;73(3):1355–1363.
- Yesil G, Aralasmak A, Akyuz E, et al. Expanding the phenotype of homozygous KCNMA1 mutations; dyskinesia, epilepsy, intellectual disability, cerebellar and corticospinal tract atrophy. Balkan Med J. 2018;35(4):336–339.
- Tabarki B, AlMajhad N, AlHashem A, et al. Homozygous KCNMA1 mutation as a cause of cerebellar atrophy, developmental delay and seizures. Hum Genet. 2016;135(11):1295–1298.
- Reiss SM, Prenatal Diagnostic AL. Testing challenges with novel gene alterations in KCNMA1-linked channelopathy: a case report. Annual Clinical Genetics Meeting; 2021 April. https://acmg.planion.com/Web.User/AbstractDet?ACCOUNT=ACMG&ABSID=10843&CONF=AM21&ssoOverride=OFF&CKEY=
- Zhang ZB, Tian MQ, Gao K, et al. De novo KCNMA1 mutations in children with early-onset paroxysmal dyskinesia and developmental delay. Mov Disord. 2015;30(9):1290–1292.
- Heim J, Vemuri A, Lewis S, et al. Cataplexy in patients harboring the KCNMA1 p.N999S mutation. Mov Disord Clin Pract. 2020;7(7):861–862.
- Bruno MK, Lee HY, Auburger GW, et al. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology. 2007;68(21):1782–1789.
- McGuire S, Chanchani S, Khurana DS. Paroxysmal dyskinesias. Semin Pediatr Neurol. 2018;25:75–81.
- Bhatia KP. Paroxysmal dyskinesias. Mov Disord. 2011;26(6):1157–1165.
- Sanders L. DIAGNOSIS: KCNMA1: just 21 people are known to have this rare genetic condition. Can you help us find more? N Y Times. 2018 August;23:2018.
- Sanders L. DIAGNOSIS: the boy slumped to the floor. Could these be seizures? N Y Times. 2020 June;3:2020.
- Braverman A Epidose #4: looking for a village. Netflix; 2019. Scott Rudin EB, Garrett Basch, P.G. Morgan, Jonathan Chinn, Simon Chinn.
- Parmar A, Murray BJ, Narang I. Clinical characteristics of cataplectic attacks in type 1 narcolepsy. Curr Neurol Neurosci Rep. 2020;20(9):38.
- Gibson R, Galentine W, Gunduz MT, et al. Novel phenotype of paroxysmal spells due to KCNMA1 de novo gene mutation mimicking epilepsy and responding to stimulant therapy. Abst. 3.446. In: American Epilespy Society Meeting; 2018. Washington, DC.
- Lima FCB, Do Nascimento Junior EB, Teixeira SS, et al. Thinking outside the box: cataplexy without narcolepsy. Sleep Med. 2019;61:118–121.
- Ewida A, Waseem F, Fahimi G, et al. Yet another N995S case, but with a second mutation (Exon 1, c.34_36dupAGC (p.Ser12dup)). In: American Epilespy Society Meeting; 2019. Baltimore, MD.
- Wang J, Yu S, Zhang Q, et al. KCNMA1 mutation in children with paroxysmal dyskinesia and epilepsy: case report and literature review. Transl Sci Rare Dis. 2017;2:8.
- Ewida A, Ghonim HT, Waseem F, et al. An unusual case of paroxysmal kinesigenic dyskineSIA (PKD) with epilepsy associated with KCNMA1 gene mutation. In: American Epilepsy Society Meeting; 2019. Baltimore, MD.
- Lek M, Karczewski KJ, Minikel EV, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–291.
- Chen Y, Lu J, Pan H, et al. Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol. 2003;54(2):239–243.
- Heron SE, Khosravani H, Varela D, et al. Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants. Annals of Neurology. 2007;62(6):560–568.
- Khosravani H, Bladen C, Parker DB, et al. Effects of Cav3. 2 channel mutations linked to idiopathic generalized epilepsy. Annals of Neurology. 2005;57(5):745–749.
- Klassen T, Davis C, Goldman A, et al. Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. Cell. 2011;145(7):1036–1048.
- Chambers C, Jansen LA, Dhamija R. Review of commercially available epilepsy genetic panels. J Genet Couns. 2016;25(2):213–217.
- Rimmer A, Phan H, Mathieson I, et al. Integrating mapping-, assembly-and haplotype-based approaches for calling variants in clinical sequencing applications. Nat Genet. 2014;46(8):912–918.
- O’Rawe J, Jiang T, Sun G, et al. Low concordance of multiple variant-calling pipelines: practical implications for exome and genome sequencing. Genome Med. 2013;5(3):28.
- Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science. 2002;296(5576):2225–2229.
- Devinsky O, Asato M, Camfield P, et al. Delivery of epilepsy care to adults with intellectual and developmental disabilities. Neurology. 2015;85(17):1512–1521.
- Berg AT, Loddenkemper T, Baca CB. Diagnostic delays in children with early onset epilepsy: impact, reasons, and opportunities to improve care. Epilepsia. 2014;55(1):123–132.
- Hagemann G, Lemieux L, Free SL, et al. Cerebellar volumes in newly diagnosed and chronic epilepsy. J Neurol. 2002;249(12):1651–1658.
- Mirkowski MN Cognitive function in BK channel knock-out mice [Thesis]. London, Ontario, Canada: Western University; 2013.
- Matthews EA, Weible AP, Shah S, et al. The BK-mediated fAHP is modulated by learning a hippocampus-dependent task. Proc Natl Acad Sci. 2008;105(39):15154–15159.
- Kshatri A, Cerrada A, Gimeno R, et al. Differential regulation of BK channels by fragile X mental retardation protein. J General Physiol. 2020;152:6.
- Choi T-Y, Lee S-H, Kim Y-J, et al. Cereblon maintains synaptic and cognitive function by regulating BK channel. J Neurosci. 2018;38(14):3571–3583.
- Higgins JJ, Tal AL, Sun X, et al. Temporal and spatial mouse brain expression of cereblon, an ionic channel regulator involved in human intelligence. J Neurogenet. 2010 Mar;24(1):18–26.
- Song T, Liang S, Liu J, et al. CRL4 antagonizes SCFFbxo7-mediated turnover of cereblon and BK channel to regulate learning and memory. PLoS Genet. 2018;14(1):e1007165.
- Choi TY, Lee SH, Kim SJ, et al. BK channel blocker paxilline attenuates thalidomide-caused synaptic and cognitive dysfunctions in mice. Sci Rep. 2018;8(1):17653.
- Hébert B, Pietropaolo S, Même S, et al. Rescue of fragile X syndrome phenotypes in Fmr1KO mice by a BKCa channel opener molecule. Orphanet J Rare Dis. 2014;9(1):124.
- Hafidi A, Beurg M, Dulon D. Localization and developmental expression of BK channels in mammalian cochlear hair cells. Neuroscience. 2005;130(2):475–484.
- MacDonald SH, Ruth P, Knaus HG, et al. Increased large conductance calcium-activated potassium (BK) channel expression accompanied by STREX variant downregulation in the developing mouse CNS. BMC Dev Biol. 2006;6:37.
- Contet C, Goulding SP, Kuljis DA, et al. BK channels in the central nervous system. Int Rev Neurobiol. 2016;128:281–342.
- Liu Y, Lopez‐Santiago LF, Yuan Y, et al. Dravet syndrome patient‐derived neurons suggest a novel epilepsy mechanism. Ann Neurol. 2013;74(1):128–139.
- Chopra R, Isom LL. Untangling the Dravet syndrome seizure network: the changing face of a rare genetic epilepsy: the paradox of Dravet syndrome. Epilepsy Curr. 2014;14(2):86–89.
- Auerbach DS, Jones J, Clawson BC, et al. Altered cardiac electrophysiology and SUDEP in a model of Dravet syndrome. PLoS One. 2013;8(10):e77843.
- Chen C, Westenbroek RE, Xu X, et al. Mice lacking sodium channel β1 subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J Neurosci. 2004;24(16):4030–4042.
- Van Wart A, Matthews G. Impaired firing and cell-specific compensation in neurons lacking nav1. 6 sodium channels. J Neurosci. 2006;26(27):7172–7180.
- N’Gouemo P. BKCa channel dysfunction in neurological diseases. Front Physiol. 2014;5:373.
- Montgomery JR, Meredith AL. Genetic activation of BK currents in vivo generates bidirectional effects on neuronal excitability. Proc Natl Acad Sci. 2012;109(46):18997–19002.
- Jaffe DB, Wang B, Brenner R. Shaping of action potentials by type I and type II large-conductance Ca2+-activated K+ channels. Neuroscience. 2011;192:205–218.
- Ly C, Melman T, Barth AL, et al. Phase-resetting curve determines how BK currents affect neuronal firing. J Comput Neurosci. 2011;30(2):211–223.
- Sheehan JJ, Benedetti BL, Barth AL. Anticonvulsant effects of the BK-channel antagonist paxilline. Epilepsia. 2009;50(4):711–720.
- Tanner MR, Beeton C. Differences in ion channel phenotype and function between humans and animal models. Front Biosci (Landmark Ed). 2018;23:43–64.
- Kratschmer P, Lowe SA, Buhl E, et al. Impaired pre-motor circuit activity and movement in a drosophila model of KCNMA1-linked dyskinesia. Mov Disord. 2021;36(5):1158–1169.
- Auton A, Abecasis GR, Altshuler DM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74.
- Sherry ST, Ward MH, Kholodov M, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308–311.
- Laumonnier F, Roger S, Guerin P, et al. Association of a functional deficit of the BKCa channel, a synaptic regulator of neuronal excitability, with autism and mental retardation. Am J Psychiatry. 2006;163(9):1622–1629.
- Levine JB, Morrow EM, Berdichevsky Y, et al. BKca channel in autism and mental retardation. Am J Psychiatry. 2007;164(6):977–978.
- Lee CG, Lee J, Lee M. Multi-gene panel testing in Korean patients with common genetic generalized epilepsy syndromes. PLoS One. 2018;13(6):e0199321.
- Burns L, Minster R, Demirci F, et al. Replication study of genome‐wide associated SNPs with late‐onset Alzheimer’s disease. Am J Med Genet B Neuropsychiatr Genet. 2011;156(4):507–512.
- Plante AE, Lai MH, Lu J, et al. Effects of single nucleotide polymorphisms in human KCNMA1 on BK current properties. Front Mol Neurosci. 2019;12:285.
- Anttila V, Nyholt DR, Kallela M, et al. Consistently replicating locus linked to migraine on 10q22-q23. Am J Hum Genet. 2008;82(5):1051–1063.
- Al-Karagholi MA, Ghanizada H, Nielsen CAW, et al. Opening of BKCa channels alters cerebral hemodynamic and causes headache in healthy volunteers. Cephalalgia. 2020;40(11):1145–1154.
- Zhang X, Ni Y, Liu Y, et al. Screening of noise-induced hearing loss (NIHL)-associated SNPs and the assessment of its genetic susceptibility. Environ Health. 2019;18(1):30.
- Kendler KS, Kalsi G, Holmans PA, et al. Genomewide association analysis of symptoms of alcohol dependence in the molecular genetics of schizophrenia (MGS2) control sample. Alcohol Clin Exp Res. 2011;35(5):963–975.
- Drgon T, Johnson CA, Nino M, et al. “Replicated” genome wide association for dependence on illegal substances: genomic regions identified by overlapping clusters of nominally positive SNPs. Am J Med Genet B Neuropsychiatr Genet. 2011;156(2):125–138.
- Obeidat M, Zhou G, Li X, et al. The genetics of smoking in individuals with chronic obstructive pulmonary disease. Respir Res. 2018;19(1):59.
- Dopico AM, Bukiya AN, Kuntamallappanavar G, et al. Modulation of BK channels by ethanol. Int Rev Neurobiol. 2016;128:239–279.
- Salvi E, Kutalik Z, Glorioso N, et al. Genome-wide association study using a high-density SNP-array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of eNOS. Hypertension. 2012;59(2):248.
- Tomas M, Vazquez E, Fernandez-Fernandez JM, et al. Genetic variation in the KCNMA1 potassium channel α subunit as risk factor for severe essential hypertension and myocardial infarction. J Hypertens. 2008;26(11):2147–2153.
- Morrison AC, Felix JF, Cupples LA, et al. Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium. Circulation. 2010;3(3):248–255.
- Fernández-Fernández JM, Tomás M, Vázquez E, et al. Gain-of-function mutation in the KCNMB1 potassium channel subunit is associated with low prevalence of diastolic hypertension. J Clin Investig. 2004;113(7):1032–1039.
- Kelley-Hedgepeth A, Peter I, Montefusco MC, et al. The KCNMB1 E65K variant is associated with reduced central pulse pressure in the community-based Framingham offspring cohort. J Hypertens. 2009;27(1):55.
- Kokubo Y, Iwai N, Tago N, et al. Association analysis between hypertension and CYBA, CLCNKB, and KCNMB1 functional polymorphisms in the Japanese population. Circ J. 2005;69(2):138–142.
- Nielsen T, Burgdorf KS, Grarup N, et al. The KCNMB1 Glu65Lys polymorphism associates with reduced systolic and diastolic blood pressure in the Inter99 study of 5729 Danes. J Hypertens. 2008;26(11):2142–2146.
- Kohler R. Single-nucleotide polymorphisms in vascular Ca2+-activated K+-channel genes and cardiovascular disease. Pflugers Arch. 2010 Jul;460(2):343–351.
- Sentí M, Fernández-Fernández JM, Tomás M, et al. Protective effect of the KCNMB1 E65K genetic polymorphism against diastolic hypertension in aging women and its relevance to cardiovascular risk. Circ Res. 2005;97(12):1360–1365.
- Rasmussen ER, Hallberg P, Baranova EV, et al. Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment. Pharmacogenomics J. 2020;20:770–783.
- Purkey MT, Li J, Mentch F, et al. Genetic variation in genes encoding airway epithelial potassium channels is associated with chronic rhinosinusitis in a pediatric population. PLoS One. 2014;9(3):e89329.
- Ueno K, Aiba Y, Hitomi Y, et al. Integrated GWAS and mRNA microarray analysis identified IFNG and CD40L as the central upstream regulators in primary biliary cholangitis. Hepatol Commun. 2020;4(5):724–738.
- Savas S, Briollais L, Ibrahim-zada I, et al. A whole-genome SNP association study of NCI60 cell line panel indicates a role of Ca2+ signaling in selenium resistance. PLoS One. 2010;5(9):e12601.
- Choi R, Sohn I, Kim MJ, et al. Pathway genes and metabolites in thiopurine therapy in Korean children with acute lymphoblastic leukaemia. Br J Clin Pharmacol. 2019;85(7):1585–1597.
- Matimba A, Li F, Livshits A, et al. Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes. Pharmacogenomics. 2014;15(4):433–447.
- Akiyama M, Takahashi A, Momozawa Y, et al. Genome-wide association study suggests four variants influencing outcomes with ranibizumab therapy in exudative age-related macular degeneration. J Hum Genet. 2018;63(10):1083–1091.
- Jiao H, Arner P, Hoffstedt J, et al. Genome wide association study identifies KCNMA1contributing to human obesity. BMC Med Genomics. 2011;4(1):51.
- Park S, Daily JW, Song MY, et al. Gene-gene and gene-lifestyle interactions of AKAP11, KCNMA1, PUM1, SPTBN1, and EPDR1 on osteoporosis risk in middle-aged adults. Nutrition. 2020:110859. DOI: https://doi.org/10.1016/j.nut.2020.110859.
- Fan Q, Guo X, Tideman JWL, et al. Childhood gene-environment interactions and age-dependent effects of genetic variants associated with refractive error and myopia: the CREAM consortium. Sci Rep. 2016;6:25853.
- Wong Y-L, Hysi P, Cheung G, et al. Genetic variants linked to myopic macular degeneration in persons with high myopia: CREAM Consortium. PLoS One. 2019;14(8):e0220143.
- Kathiresan S, Manning AK, Demissie S, et al. A genome-wide association study for blood lipid phenotypes in the Framingham heart study. BMC Med Genet. 2007;8(1):1–10.
- Schuckit MA, Wilhelmsen K, Smith TL, et al. Autosomal linkage analysis for the level of response to alcohol. Alcohol Clin Exp Res. 2005;29(11):1976–1982.
- Tian WT, Huang XJ, Mao X, et al. Proline-rich transmembrane protein 2-negative paroxysmal kinesigenic dyskinesia: clinical and genetic analyses of 163 patients. Mov Disord. 2018;33(3):459–467.
- Wu H, Li H, Bai T, et al. Phenotype-to-genotype approach reveals head-circumference-associated genes in an autism spectrum disorder cohort. Clin Genet. 2020;97(2):338–346.
- Landrum MJ, Lee JM, Benson M, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062–D1067.
- Karczewski KJ, Francioli LC, Tiao G, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581(7809):434–443.